yumab-logo
icon-we-are-yumab

We are Yumab

Profile & Vision

Bridging the gap from target to lead

YUMAB delivers leads for next generation antibody medicines in a rapid, robust, and reliable process. Our team is committed to bridging the gap between research and novel therapies with innovative technologies, proven strategies, and tailored services.

The company’s advanced discovery platform provides access to challenging targets, enables new formats, and accelerates the development of human antibodies at a high success rate.

YUMAB – pioneering antibody discovery since 2012

From target discovery to fully characterized lead – our experienced team leads biotech and pharma teams worldwide through the development process as your trusted, de-risking partner.

Discover more in our corporate image video!

Antibody is our business

Partnering

• Hit discovery, target identification
• Lead engineering & development

Contract research

• Antibody engineering / optimization
• Antibody humanization

multi-y-trenner-01

Milestones

2012 | Founding of YUMAB GmbH

2012 | Founding of YUMAB GmbH

Founding of a biotechnology company by experts and pioneers in recombinant antibody technologies of the University of Braunschweig in Germany.   # of employees: 1

2013 | First booth participation at Biotechnica in Hannover and Bio Europe

2013 | First booth participation at Biotechnica in Hannover and Bio Europe

The first time on a conference stage at major trade shows to grab attention which clearly influenced the path and strategy of the YUMAB business model. # of employees: 2

2016 IHK Technology Transfer Award

2016 IHK Technology Transfer Award

YUMAB received the IHK Technology Transfer Award for the transfer of antibody generation technologies to industry. # of employees: 10

2017 | Innovation Award Niedersachsen

2017 | Innovation Award Niedersachsen

For the development of human antibodies, YUMAB and TU Braunschweig received the Innovation Network Lower Saxony Award (1st place). # of employees: 14

2017 | Founding of YUMAB Inc. Atlanta Georgia

2017 | Founding of YUMAB Inc. Atlanta Georgia

Founding of the US subsidiary to be able to serve the American market more intensively. # of employees: 14

2018 | Relocation to the campus of the Helmholtz-Centre for Infection Research

2018 | Relocation to the campus of the Helmholtz-Centre for Infection Research

Open house day with many interesting participants from the press, politics and science. # of employees: 20

2020 | Spin-Off CORAT Therapeutics GmbH

2020 | Spin-Off CORAT Therapeutics GmbH

Fighting COVID-19 with recombinant fully human antibodies. # of employees: 25

2022 | New Logo & Corporate Design

2022 | New Logo & Corporate Design

Our new logo – 2022 and beyond! # of employees: 30

2022 | YUMAB Anniversary Event

2022 | YUMAB Anniversary Event

yumab in numbers

partners
0
projects
0
fundings
0
antibodies
Libraries
Employees
laboratories m²
coffees
creative beers
Babies
dogs
office m²
conferences
team events
multi-y-trenner-02

yumab Locations

YUMAB’s home is Braunschweig. The Technical University is the place where it all started and the Science Campus Braunschweig-Süd as an internationally renowned research hub is the current location of the company’s headquarters. To facilitate business in the USA, YUMAB has opened a subsidiary in 2017 in Atlanta, Georgia.

YUMAB GmbH

YUMAB Inc.

multi-y-trenner-03

YUMAB GMBH

YUMAB GMBH

People